共 50 条
- [1] Phase 2 Trial of Continuous Course Re-irradiation Concurrent With Weekly Cisplatinum and Cetuximab for Recurrent Squamous Cell Carcinoma of the Head and Neck: Preliminary Report [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S179 - S179
- [2] Re-irradiation with Cetuximab in relapsed squamous cell carcinoma of the head and neck (HNC) [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 492 - 493
- [4] Erratum to: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck [J]. Strahlentherapie und Onkologie, 2015, 191 : 763 - 764
- [8] Dose intense re-irradiation and chemotherapy for recurrent head and neck squamous cell carcinoma [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S490 - S491
- [9] Outcomes of Phase I Trial of Patients With Recurrent Head and Neck Squamous Cell Carcinoma Treated With Re-Irradiation With Stereotactic Body Radiation Therapy and Concurrent Cisplatin [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E369 - E369
- [10] Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [J]. IN VIVO, 2020, 34 (05): : 2653 - 2657